Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Record History now lists revision v3.3.2 and removes v3.3.1, updating the version history.
    Difference
    0.1%
    Check dated 2025-11-28T04:15:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and Revision: v3.2.0 was removed in the record history.
    Difference
    0.1%
    Check dated 2025-11-21T00:47:01.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Removed the generic notice about government funding and potential delays, including links to cc.nih.gov and opm.gov for operating-status updates.
    Difference
    0.8%
    Check dated 2025-11-13T21:48:35.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    No substantive changes to the listed study record versions or dates; the screenshots show only minor visual/layout tweaks to the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-30T12:06:48.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.2.0. This indicates a new version release, but does not alter core content or other important data.
    Difference
    0.3%
    Check dated 2025-10-01T04:50:07.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-30T03:44:26.000Z thumbnail image

Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.